Supplemental oxygen prescriptions after hospitalization for coronavirus disease 2019.

Background: The role of home oxygen therapy for patients recovering from Coronavirus Disease 2019 (COVID-19) pneumonia, characterized by impaired gas exchange, is not well-defined.

Objectives: To compare the characteristics, duration, odds of receiving, and continuing to receive home oxygen prescriptions between patients discharged home after COVID-19 pneumonia hospitalization and those discharged after non-COVID-19 pneumonia.

Methods: From April 2020 to March 2021, 52,951 patients with COVID-19 pneumonia (53.

Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019.

Rationale: There is controversy concerning the association of chronic obstructive pulmonary disease (COPD) as an independent risk factor for mortality in patients hospitalized with Coronavirus Disease 2019 (COVID-19). We hypothesize that patients with COPD hospitalized for COVID-19 have increased mortality risk.

Objective: To assess whether COPD increased the risk of mortality among patients hospitalized for COVID-19.

Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.

Implementation of the Hospital Readmissions Reduction Program (HRRP) following discharge of patients with chronic obstructive pulmonary disease (COPD) has led to a reduction in 30-day readmissions with unknown effects on postdischarge mortality. To examine the association of HRRP with 30-day hospital readmission and 30-day postdischarge mortality rate in patients after discharge from COPD hospitalization. Retrospective cohort study of readmission and mortality rates in a national cohort ( = 4,587,542) of admissions of Medicare fee-for-service beneficiaries 65 years or older with COPD from 2006 to 2017.